cd30 and tumor progression in hodgkin lymphoma
Published 9 years ago • 1K plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
1:15
cd30, a promising target for car-t therapy in hodgkin lymphoma
-
1:16
dual-targeting cd30/pdl1 car-t therapy in hodgkin lymphoma
-
8:26
targeting cd30 in classical hodgkin lymphoma
-
6:57
brentuximab vedotin in cd30-positive lymphoma
-
0:53
cd30-specific car t cells in patients with relapsed/refractory hodgkin lymphoma
-
2:39
peripheral t-cell lymphoma classifications and cd30 testing
-
5:14
brentuximab vedotin in hodgkin lymphoma
-
1:31
is cd30 an accurate diagnostic marker in lymphomas other than hodgkin lymphoma?
-
2:11
dr. zelenetz discusses cd30 as a target in lymphoma
-
0:55
lymphoma signs & symptoms
-
1:25
dr. o'connor on cd30 expression in dlbcl
-
3:51
treating patients with cd30-positive ptcl
-
0:29
no cancer is a good cancer
-
1:42
infusion of cd30 car t-cells following auhct in patients with lymphoma
-
1:15
dr. advani discusses cd30 as a target and brentuximab vedotin in alcl
-
1:31:25
precision medicine in cd30- and cd123-expressing hematologic cancers
-
3:34
evolving role of brentuximab vedotin in hodgkin lymphoma
-
16:11
cd30 cell graphs of hodgkin lymphoma are not scale-free—an... - tim schäfer - highlights - ismb 2016
-
4:06
cd30-directed car-ts co-expressing ccr4 in r/r hl and cd30 ctcl